Our first article in this series highlighted the financial and reputational damage counterfeiting causes to brand owners and the significant ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

Find out the direct holders, institutional holders and mutual fund holders for Microchip Technology Incorporated (MCHP).